Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00018070
What this trial is testing

Identification and Treatment of Feeder Vessels in Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00001615
What this trial is testing

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 180
Not applicableStudy completedNCT02446067
What this trial is testing

Cerebral Hemodynamics With rTMS in Alcohol Dependence

Who this might be right for
Alcohol Dependence
Central Institute of Psychiatry, Ranchi, India 75
Testing effectiveness (Phase 2)UnknownNCT06265454
What this trial is testing

Low Dose Atropine Eye Drops in Myopic Egyptian Children

Who this might be right for
Myopia ProgressionAxial Length, EyeSclera Thickness
Ain Shams University 75
Early research (Phase 1)Study completedNCT01968486
What this trial is testing

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60
Not applicableStudy completedNCT03359551
What this trial is testing

Natural History of the Progression of Choroideremia Study

Who this might be right for
Choroideremia
NightstaRx Ltd, a Biogen Company 319
Large-scale testing (Phase 3)Study completedNCT01217944
What this trial is testing

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Pathological Myopia
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)UnknownNCT00100087
What this trial is testing

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Theragenics Corporation 30
Not applicableStudy completedNCT04795206
What this trial is testing

Natural Disease Progression in Participants With Choroideremia

Who this might be right for
Choroideremia
Biogen 1,178
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Testing effectiveness (Phase 2)UnknownNCT02934841
What this trial is testing

Conbercept in Choroidal Neovascularization Secondary to Uveitis

Who this might be right for
Choroidal NeovascularizationUveitis
Chongqing Medical University 40
Not applicableEnded earlyNCT00272766
What this trial is testing

Macugen for Histoplasmosis

Who this might be right for
Ocular HistoplasmosisChoroidal Neovascularization
Barnes Retina Institute 24
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Not applicableUnknownNCT02847312
What this trial is testing

Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure

Who this might be right for
Healthy
University of Reading 30
Post-approval studies (Phase 4)Study completedNCT01148511
What this trial is testing

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 99
Testing effectiveness (Phase 2)WithdrawnNCT03374670
What this trial is testing

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Not applicableLooking for participantsNCT07628946
What this trial is testing

Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy

Who this might be right for
Ocular Surface DiseaseInflammatory DiseaseRetinal Disease+1 more
Dan Chen 3,000
Next Page